OpenLB
Open Library of Bioscience
Advanced Search
Infectious diseases and therapy
Aug, 2023;12 (8): 1937-1954.

Herpes Zoster Burden of Disease and Clinical Management in Turkey: A Comprehensive Literature Review.

Selim Badur, Esin Senol, Alpay Azap, Cihan Yesiloglu, Alev Ozakay, Serdar Ozturk, Adriana Guzman-Holst
Author Information
  1. Selim Badur: GSK, Istanbul, Turkey. ORCID
  2. Esin Senol: Gazi University, Ankara, Turkey. ORCID
  3. Alpay Azap: Ankara University, Ankara, Turkey. ORCID
  4. Cihan Yesiloglu: GSK, Istanbul, Turkey. ORCID
  5. Alev Ozakay: GSK, Istanbul, Turkey. ORCID
  6. Serdar Ozturk: GSK, Istanbul, Turkey. ORCID
  7. Adriana Guzman-Holst: GSK Vaccines, 20 Avenue Fleming, 1300, Wavre, Belgium. adriana.x.guzman@gsk.com. ORCID
PMID: 37530949 DOI: 10.1007/s40121-023-00849-3

Abstract

INTRODUCTION: Herpes zoster (HZ), or shingles, is caused by the reactivation of varicella zoster virus (VZV) and typically presents as an acute, painful dermatomal rash, but can lead to long-term, distressing complications such as postherpetic neuralgia (PHN). Increasing trends in HZ cases are evident globally among the aging population; however, reviews investigating the epidemiology and clinical management of HZ in Turkey are lacking. Therefore, a literature review of local studies in Turkey was conducted to identify the data available and identify gaps in the literature.
METHODS: Literature searches were carried out in PubMed and local journals to retrieve published articles that reported surveillance data, seroepidemiology, patient outcomes, or clinical management related to HZ or VZV in Turkey until April 30, 2022. Studies included primary data reports, case studies, secondary data reviews, and epidemiological studies in healthy or at-risk populations; HZ was the primary focus of the review.
RESULTS: No studies reported VZV or HZ epidemiological data at a national level. One large retrospective study in Istanbul reported that HZ incidence rates significantly increased in adults 18-44 years of age between 2011 and 2019. Four single-center studies reported the proportion of dermatological patients with HZ at 0.43-1.56%. PHN was the most common reported complication, occurring in 8-58.9% of patients with HZ. However, out of 39 identified case reports, HZ ophthalmicus was the most frequently reported complication. Two studies highlighted poor disease awareness and risk perception of HZ among Turkish citizens.
CONCLUSION: Overall, there were limited comprehensive epidemiological data on HZ in Turkey. However, the abundance of case studies on HZ complications indicates a strong disease presence and diverse clinical management in Turkey. Further research will be important to understand the impact of HZ, increase disease awareness, and support the introduction of new preventative strategies.

Keywords

Chickenpox Herpes zoster Shingles Turkey Varicella zoster virus

References

  1. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965;58(1):9–20. [PMID: 14267505]
  2. Harbecke R, Cohen JI, Oxman MN. Herpes zoster vaccines. J Infect Dis. 2021;224(12 Suppl 2):S429–42. https://doi.org/10.1093/infdis/jiab387 . [DOI: 10.1093/infdis/jiab387]
  3. Arvin AM. Varicella-zoster virus. Clin Microbiol Rev. 1996;9(3):361–81. https://doi.org/10.1128/cmr.9.3.361 . [DOI: 10.1128/cmr.9.3.361]
  4. Curran D, Schmidt-Ott R, Schutter U, Simon J, Anastassopoulou A, Matthews S. Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above. BMC Infect Dis. 2018;18(1):496. https://doi.org/10.1186/s12879-018-3395-z . [DOI: 10.1186/s12879-018-3395-z]
  5. van Oorschot D, Vroling H, Bunge E, Diaz-Decaro J, Curran D, Yawn B. A systematic literature review of herpes zoster incidence worldwide. Hum Vaccin Immunother. 2021;17(6):1714–32. https://doi.org/10.1080/21645515.2020.1847582 . [DOI: 10.1080/21645515.2020.1847582]
  6. Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4(6): e004833. https://doi.org/10.1136/bmjopen-2014-004833 . [DOI: 10.1136/bmjopen-2014-004833]
  7. Thompson RR, Kong CL, Porco TC, Kim E, Ebert CD, Acharya NR. Herpes zoster and postherpetic neuralgia: changing incidence rates from 1994 to 2018 in the United States. Clin Infect Dis. 2021;73(9):e3210–7. https://doi.org/10.1093/cid/ciaa1185 . [DOI: 10.1093/cid/ciaa1185]
  8. Grote V, von Kries R, Rosenfeld E, Belohradsky BH, Liese J. Immunocompetent children account for the majority of complications in childhood herpes zoster. J Infect Dis. 2007;196(10):1455–8. https://doi.org/10.1086/522631 . [DOI: 10.1086/522631]
  9. Kang DH, Kwak BO, Park AY, Kim HW. Clinical manifestations of herpes zoster associated with complications in children. Children. 2021;8(10):845. https://www.mdpi.com/2227-9067/8/10/845 .
  10. United Nation, Department of Economic and Social Affairs, Population Division. World Population prospects: the 2012 revision. New York: United Nations, Department of Economic and Social Affairs, Population Division; 2013:4.
  11. Worldometer. Turkey population. https://www.worldometers.info/world-population/turkey-population/ . Accessed July 25, 2023.
  12. Turkish Statistical Institute. Elderly statistics, 2014, vol. 7. Ankara: Turkish Statistical Institute; 2015.
  13. Pan CX, Lee MS, Nambudiri VE. Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review. Ther Adv Vaccines Immunother. 2022;10:25151355221084536. https://doi.org/10.1177/25151355221084535 . [DOI: 10.1177/25151355221084535]
  14. Patil A, Goldust M, Wollina U. Herpes zoster: a review of clinical manifestations and management. Viruses. 2022;14(2):192. https://doi.org/10.3390/v14020192 . [DOI: 10.3390/v14020192]
  15. Varela FH, Pinto LA, Scotta MC. Global impact of varicella vaccination programs. Hum Vaccin Immunother. 2019;15(3):645–57. https://doi.org/10.1080/21645515.2018.1546525 . [DOI: 10.1080/21645515.2018.1546525]
  16. Wolfson LJ, Daniels VJ, Pillsbury M, et al. Cost-effectiveness analysis of universal varicella vaccination in Turkey using a dynamic transmission model. PLoS ONE. 2019;14(8): e0220921. https://doi.org/10.1371/journal.pone.0220921 . [DOI: 10.1371/journal.pone.0220921]
  17. Devlet malzeme ofisi. Suçiçeği aşisi teknik şartnamesi. https://www.dmo.gov.tr/Files/IhaleDosyalari/15224/15224-2-teknik%20%C5%9Fartname.pdf . Accessed July 10, 2023.
  18. World Health Organization. Vaccination schedule for Türkiye. https://immunizationdata.who.int/pages/schedule-by-country/tur.html . Accessed July 07, 2022.
  19. Wohlin C. Guidelines for snowballing in systematic literature studies and a replication in software engineering. In: Proceedings of the 18th International Conference on Evaluation and Assessment in Software Engineering. London: Association for Computing Machinery; 2014:Article 38.
  20. Dinleyici EC, Kurugol Z, Turel O, et al. The epidemiology and economic impact of varicella-related hospitalizations in Turkey from 2008 to 2010: a nationwide survey during the pre-vaccine era (VARICOMP study). Eur J Pediatr. 2012;171(5):817–25. https://doi.org/10.1007/s00431-011-1650-z . [DOI: 10.1007/s00431-011-1650-z]
  21. Soysal A, Gönüllü E, Yıldız İ, Karaböcüoğlu M. Incidence of varicella and herpes zoster after inclusion of varicella vaccine in national immunization schedule in Turkey: time trend study. Hum Vaccin Immunother. 2021;17(3):731–7. https://doi.org/10.1080/21645515.2020.1788861 . [DOI: 10.1080/21645515.2020.1788861]
  22. Alp H, Altınkaynak S, Ertekin V, Kılıçaslan B, Giiraksin A. Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern Turkey. Health Policy. 2005;72(1):119–24. https://doi.org/10.1016/j.healthpol.2004.03.008 . [DOI: 10.1016/j.healthpol.2004.03.008]
  23. Kanra G, Tezcan S, Badur S. Varicella seroprevalence in a random sample of the Turkish population. Vaccine. 2002;20(9–10):1425–8. https://doi.org/10.1016/s0264-410x(01)00459-5 . [DOI: 10.1016/s0264-410x(01)00459-5]
  24. Kose S, Mandiracioglu A, Senger SS, et al. Seroprevalence of varicella-zoster virus in the prevaccine era: a population-based study in Izmir. Turkey J Infect Public Health. 2013;6(2):115–9. https://doi.org/10.1016/j.jiph.2012.10.003 . [DOI: 10.1016/j.jiph.2012.10.003]
  25. Koturoglu G, Kurugol Z, Turkoglu E. Seroepidemiology of varicella-zoster virus and reliability of varicella history in Turkish children, adolescents and adults. Paediatr Perinat Epidemiol. 2011;25(4):388–93. https://doi.org/10.1111/j.1365-3016.2010.01180.x . [DOI: 10.1111/j.1365-3016.2010.01180.x]
  26. Atiş G, Aydinİlknur E, Altunay I. Herpes zoster in geriatric patients: Clinical course and complications. Turk Geriatri Dergisi. 2017;20(3):172–7.
  27. Özkol HU, Bilgili SG, Karadağ AS, Altun F, Çalka Ö. Türkiye’nin Doğusundaki Herpes Zoster Tanılı 115 Hastanın Klinik ve Demografik Özelliklerinin Değerlendirilmesi. Turk J Dermatol. 2013;7:201–5. https://doi.org/10.4274/tdd.1627 . [DOI: 10.4274/tdd.1627]
  28. Küçükçakır O, Aliağaoğlu C, Turan H, et al. 1999–2010 yılları arasında kliniğimizde takip edilen herpes zoster olgularının retrospektif değerlendirilmesi. Türkderm. 2012;46:186–90. https://doi.org/10.4274/turkderm.93265 . [DOI: 10.4274/turkderm.93265]
  29. Dogan S, Bildik B, Karaboga T, Kalafat UM, Yesiltas I, Ozucelik DN. Evaluation of patients diagnosed with herpes zoster in emergency departments. Res J Life Sci Bioinform Pharm Chem Sci. 2019;5(1):195–202.
  30. Kartal D, Çınar SL, Akın S, Ferahbaş A, Borlu M. Skin findings of geriatric patients in Turkey: a 5-year survey. Dermatol Sin. 2015;33(4):196–200. https://doi.org/10.1016/j.dsi.2015.04.001 . [DOI: 10.1016/j.dsi.2015.04.001]
  31. Yavuzcan G. Prevalence of skin disorders among geriatric patients in the Black Sea region of Turkey. J Exp Clin Med. 2022;39(2):327–33. https://doi.org/10.52142/omujecm.39.2.4 . [DOI: 10.52142/omujecm.39.2.4]
  32. Çeltek NY, Ünlü U. Evaluation of zona zoster cases occuring in cancer diagnosed patients. TJFMP. 2020;14(6):646–50. https://doi.org/10.21763/tjfmpc.766986 . [DOI: 10.21763/tjfmpc.766986]
  33. Bilen A. Evaluation of patients with postherpetic neuralgia admitted to pain clinic. Klimik Derg. 2020;33(1):52–4. https://doi.org/10.5152/kd.2020.10 . [DOI: 10.5152/kd.2020.10]
  34. Ozturk S, Akoglu EU, Arikan EE, Agalar C. Menopausal transition may affect the onset of herpes zoster: an update on herpes zoster vaccine. Ann Med Res. 2021;28(8):1515–9. https://doi.org/10.5455/annalsmedres.2020.09.961 . [DOI: 10.5455/annalsmedres.2020.09.961]
  35. Senol E, Azap A, Kutlu SS, et al. Demographical and clinical evaluation of herpes zoster in Turkey: a retrospective multicentre study, the VARICOMP adult study [Congress Abstract P0060]. The 28th European Congress of Clinical Microbiology and Infectious Diseases. 2018.
  36. Ku H-C, Tsai Y-T, Konara-Mudiyanselage S-P, Wu Y-L, Yu T, Ko N-Y. Incidence of herpes zoster in HIV-infected patients undergoing antiretroviral therapy: a systematic review and meta-analysis. J Clin Med. 2021;10(11):2300. [DOI: 10.3390/jcm10112300]
  37. Glesby MJ, Moore RD, Chaisson RE. Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus. Clin Infect Dis. 1995;21(2):370–5. https://doi.org/10.1093/clinids/21.2.370 . [DOI: 10.1093/clinids/21.2.370]
  38. Duman ZTO, Akoglu G. Disseminated herpes zoster infection in a splenectomized patient. Our Dermatol Online. 2018;9(4):456–7. https://doi.org/10.7241/ourd.20184.27 . [DOI: 10.7241/ourd.20184.27]
  39. Etgu F. Recurrent herpes zoster as a sign of HIV infection. Mid Black Sea J Health Sci. 2021;7(1):150–3. [DOI: 10.19127/mbsjohs.821860]
  40. Akalin H, Heper Y, Yilmaz E, et al. Retrospective analysis of 21 HIV/AIDS cases. Mikrobiyol Bult. 2005;39:339–43.
  41. Akin H, Bölük G, Akalin H, et al. HIV/AIDS: retrospective analysis of 78 cases. Klimik Dergisi. 2012;25(3):111–6. https://doi.org/10.5152/kd.2012.31 . [DOI: 10.5152/kd.2012.31]
  42. Altuntaş Aydin Ö, Kumbasar Karaosmanoğlu H, Korkusuz R, Özeren M, Özcan N. Mucocutaneous manifestations and the relationship to CD4 lymphocyte counts among Turkish HIV/AIDS patients in Istanbul. Turkey Turk J Med Sci. 2015;45(1):89–92. https://doi.org/10.3906/sag-1308-3 . [DOI: 10.3906/sag-1308-3]
  43. Mustafayev K, Mete B, Kutlubay Z, et al. Dermatological lesions among people living with HIV in Turkey. Int J STD AIDS. 2022;33(1):55–62. https://doi.org/10.1177/09564624211043711 . [DOI: 10.1177/09564624211043711]
  44. Gunes R, Külcü Çakmak S, Yorulmaz A. Mucocutaneous manifestation of HIV and the correlation with CD4 count and viral load: a prospective study from Turkey. Turkiye Klinikleri J Dermatol. 2020;30(3):88–94. https://doi.org/10.5336/dermato.2020-79035 . [DOI: 10.5336/dermato.2020-79035]
  45. Yardimici AC, Fincanci M. The relationship between the opportunistic diseases and viral load and CD4+ T cell count in patients with HIV infection. Klimik Dergisi. 2015;28(1):28–34. https://doi.org/10.5152/kd.2015.06 . [DOI: 10.5152/kd.2015.06]
  46. Coronavirus disease 2019 (COVID-19) Situation Report – 163. World Health Organization; 2020.
  47. Kartal SP, Çelik G, Sendur N, et al. Multicenter study evaluating the impact of COVID-19 outbreak on dermatology outpatients in Turkey. Dermatol Ther. 2020;33(6): e14485. https://doi.org/10.1111/dth.14485 . [DOI: 10.1111/dth.14485]
  48. Algaadi SA. Herpes zoster and COVID-19 infection: a coincidence or a causal relationship? Infection. 2022;50(2):289–93. https://doi.org/10.1007/s15010-021-01714-6 . [DOI: 10.1007/s15010-021-01714-6]
  49. Diez-Domingo J, Parikh R, Bhavsar AB, Cisneros E, McCormick N, Lecrenier N. Can COVID-19 increase the risk of herpes zoster? A narrative review. Dermatol Ther (Heidelb). 2021;11(4):1119–26. https://doi.org/10.1007/s13555-021-00549-1 . [DOI: 10.1007/s13555-021-00549-1]
  50. Temiz SA, Kutlu Ö. The development of dermatologic diseases in patients recovered from COVID-19. Dermatol Ther. 2021;34(2):e14791. https://doi.org/10.1111/dth.14791 . [DOI: 10.1111/dth.14791]
  51. Bostan E, Yalici-Armagan B. Herpes zoster following inactivated COVID-19 vaccine: a coexistence or coincidence? J Cosmet Dermatol. 2021;20(6):1566–7. https://doi.org/10.1111/jocd.14035 . [DOI: 10.1111/jocd.14035]
  52. Aksu SB, Öztürk GZ. A rare case of shingles after COVID-19 vaccine: is it a possible adverse effect? Clin Exp Vaccine Res. 2021;10(2):198–201. https://doi.org/10.7774/cevr.2021.10.2.198 . [DOI: 10.7774/cevr.2021.10.2.198]
  53. Acar A, Yoldaş A, Karaarslan I, et al. Retrospective evaluation of clinical features in hospitalized herpes zoster patients. Ege Tıp Dergisi. 2022;61(1):58–63. https://doi.org/10.19161/etd.1085700 . [DOI: 10.19161/etd.1085700]
  54. Acer E, Erdoğan HK, Bulur I, Acar EM. Evaluation of demographic and clinical characteristics of 166 patients with herpes zoster in the Kırşehir region. Turkderm Arch Dermatol Venerol. 2018;52:95–9.
  55. Yürük D, Yildiz Tabakoğlu A. Is postherpetic neuralgia an inevitable end in elderly cases with herpes zoster? An evaluation of age-related risk factors in the development of postherpetic neuralgia. Turk Geriatri Dergisi. 2021;24(1):41–9. https://doi.org/10.31086/tjgeri.2021.198 . [DOI: 10.31086/tjgeri.2021.198]
  56. Afşar Sİ, Uzunkulakoğlu A, Karataş M. Brachial plexopathy associated with herpes zoster infection: report of two cases and review of the literature. J PMR Sci. 2016;19:55–7.
  57. Aktaş İ, Akgün K, Gündüz OH. Axillary mononeuropathy after herpes zoster infection mimicking subacromial impingement syndrome. Am J Phys Med Rehabil. 2008;87(10):859–61. https://doi.org/10.1097/PHM.0b013e318186bb95 . [DOI: 10.1097/PHM.0b013e318186bb95]
  58. Alpay K, Yandt M. Herpes zoster and Ogilvie’s syndrome. Dermatology. 1994;189(3):312. https://doi.org/10.1159/000246870 . [DOI: 10.1159/000246870]
  59. Araz C, Aşkin S, Yılmaz C. Herpes zoster brachial plexopathy: direct steroid injection. Turk Neurosurg. 2017;27(4):662–4. https://doi.org/10.3390/jcm10112300 . [DOI: 10.3390/jcm10112300]
  60. Aydin E, Balikoglu-Yilmaz M, Imre SS, Koc F, Kazanci L, Ozturk AT. A rare patient with orbital apex syndrome, anterior uveitis, and necrotizing scleritis due to herpes zoster ophthalmicus. J Craniofac Surg. 2016;27(8):e750–2. https://doi.org/10.1097/scs.0000000000003098 . [DOI: 10.1097/scs.0000000000003098]
  61. Bahadir C, Kalpakcioglu AB, Kurtulus D. Unilateral diaphragmatic paralysis and segmental motor paresis following herpes zoster. Muscle Nerve. 2008;38(2):1070–3. https://doi.org/10.1002/mus.21042 . [DOI: 10.1002/mus.21042]
  62. Bakbak B, Çelebi ARC, Şener C. Horner’s syndrome following herpes zoster ophthalmicus. Turk Norol Derg. 2009;15:82–4.
  63. Bakılan F, Ösken S, Ekim A. Complex regional pain syndrome after herpes zoster: a case report. Turk J Osteoporos. 2018;24:63–6. https://doi.org/10.4274/tod.55477 . [DOI: 10.4274/tod.55477]
  64. Balcı K, Utku U, Özbek B. Herpes zoster ophthalmicus with sixth cranial nerve palsy: a case report. Turk J Neurol. 2008;14(5):350–2.
  65. Balta S, Talu GK. Segmental zoster paresis of the lower extremity: case report. Agri. 2021. https://doi.org/10.14744/agri.2021.70846 . [DOI: 10.14744/agri.2021.70846]
  66. Büyükdemirci A, Yüksekkaya E, Cesur S, Kaya-Kılıç E, Ataman-Hatipoglu C, Kınıklı S. Encephalitis following herpes zoster ophthalmicus. Klimik Dergisi. 2020;31(2):157–60. https://doi.org/10.5152/kd.2018.37 . [DOI: 10.5152/kd.2018.37]
  67. Çevik B, Kurt S, Aksoy D, Ünaldi HK, Günal Ö, Solmaz V. Polyradiculitis and transverse myelitis secondary to herpes zoster in a liver transplant patient. Noro Psikiyatr Ars. 2013;50:193–4. https://doi.org/10.4274/npa.y6848 . [DOI: 10.4274/npa.y6848]
  68. Çınar N, Sahin S, Okluoglu T, Batum K, Karşıdağ S. Herpes radiculopathy case presenting first with motor involvement. Eur J General Med. 2011;8(3):219–23.
  69. Erden E, Öztürk GT, Ersöz M. Herpes zoster infection presenting as neurogenic bladder dysfunction. Turk J Phys Med Rehabil. 2017;63(2):199. https://doi.org/10.5606/tftrd.2017.905 . [DOI: 10.5606/tftrd.2017.905]
  70. Eren E, Kaynar L, Doganay M. Severe herpes zoster ophtalmicus in an immuncompromised patient. Erciyes Med J. 2018;40(4):240–1. https://doi.org/10.5152/etd.2017.0118 . [DOI: 10.5152/etd.2017.0118]
  71. Erol B, Avci A, Eken C, Ozgok Y. Urinary retention, erectile dysfunction and meningitis due to sacral herpes zoster: a case report and review of the literature. Urol Int. 2009;82(2):238–41. https://doi.org/10.1159/000200807 . [DOI: 10.1159/000200807]
  72. Eskiizmir G, Uz U, Taşkiran E, Unlü H. Herpes zoster oticus associated with varicella zoster virus encephalitis. Laryngoscope. 2009;119(4):628–30. https://doi.org/10.1002/lary.20111 . [DOI: 10.1002/lary.20111]
  73. Demir CF, Akalın Y, Berilgen S. Occipital neuralgia following thoracic herpes zoster: case report. Agri. 2011;23(4):179–80. https://doi.org/10.5505/agri.2011.87699 . [DOI: 10.5505/agri.2011.87699]
  74. Gurel MS, Savas S, Bilgin F, Erdil D, Leblebici C, Sarikaya E. Zosteriform pemphigoid after zoster: Wolf’s isotopic response. Int Wound J. 2016;13(1):141–2. https://doi.org/10.1111/iwj.12423 . [DOI: 10.1111/iwj.12423]
  75. Kansu L, Yilmaz I. Herpes zoster oticus (Ramsay Hunt syndrome) in children: case report and literature review. Int J Pediatr Otorhinolaryngol. 2012;76(6):772–6. https://doi.org/10.1016/j.ijporl.2012.03.003 . [DOI: 10.1016/j.ijporl.2012.03.003]
  76. Kavalci C, Findik M, Muratoglu M. A rare case in emergency: herpes zoster ophtalmicus. J Case Reports Med. 2019;8(4):1–2. https://doi.org/10.25149/jcrm.v8i3.203 . [DOI: 10.25149/jcrm.v8i3.203]
  77. Kayayurt K, Yavasi O, Bilir O, Ersunan G, Giakoup B. A case of Ramsay hunt syndrome with atypical presentation. Turk J Emerg Med. 2014;14(3):142–5. https://doi.org/10.5505/1304.7361.2014.82788 . [DOI: 10.5505/1304.7361.2014.82788]
  78. Keskinruzgar A, Demirkol M, Ege B, Aras M, Ay S. Rare involvement of herpes zoster in the mandibular branch of the trigeminal nerve: a case report and review of the literature. Quintessence Int. 2015;46(2):163–70. https://doi.org/10.3290/j.qi.a32814 . [DOI: 10.3290/j.qi.a32814]
  79. Kocaoğlu G, Utine CA, Yaman A, Men S. Orbital apex syndrome secondary to herpes zoster ophthalmicus. Turk J Ophthalmol. 2018;48(1):42–6. https://doi.org/10.4274/tjo.02256 . [DOI: 10.4274/tjo.02256]
  80. Kucukardali Y, Solmazgul E, Terekeci H, Oncul O, Turhan V. Herpes zoster ophthalmicus and syndrome of inappropriate antidiuretic hormone secretion. Intern Med. 2008;47(5):463–5. https://doi.org/10.2169/internalmedicine.47.0629 . [DOI: 10.2169/internalmedicine.47.0629]
  81. Kulakli F, Kulakli S, Ilhanli İ, Aslan A, Uysal E, Çelik C. Polymyalgia rheumatica after herpes-zoster. Arch Rheumatol. 2018;33(4):494–5. https://doi.org/10.5606/ArchRheumatol.2018.6859 . [DOI: 10.5606/ArchRheumatol.2018.6859]
  82. Kurtaran B, Paydaş S, Candevir A, Kömür S, Salih Zeki Aksu H. Disseminated herpes zoster infection in a patient with lymphoma. Turk J Med Sci. 2009;39(3):479–82. https://doi.org/10.3906/sag-0803-6 . [DOI: 10.3906/sag-0803-6]
  83. Ozel L, Toros SZ, Unal E, et al. Ramsay Hunt syndrome with atypical progress in a renal transplant recipient: a case report. Exp Clin Transplant. 2011;9(6):413–6. [PMID: 22142050]
  84. Öztop P, Saraçgil Coşar SN, Ümit Yemişci O, Varol Üre RS. Complex regional pain syndrome associated with herpes zoster: a case report. Turk J Rheumatol. 2011;26(3):254–7. https://doi.org/10.5152/tjr.2011.040 . [DOI: 10.5152/tjr.2011.040]
  85. Samanci Y, Samanci B. A case of herpes zoster infection mimicking carpal tunnel syndrome. Neurol India. 2019;67(1):272–3. https://doi.org/10.4103/0028-3886.253607 . [DOI: 10.4103/0028-3886.253607]
  86. Soydas Turan B, Bozkurt MF. Unusual presentation of herpes zoster infection mimicking soft tissue metastases of breast cancer on 18F-FDG PET/CT imaging. Clin Nucl Med. 2021;46(8):669–70. https://doi.org/10.1097/rlu.0000000000003580 . [DOI: 10.1097/rlu.0000000000003580]
  87. Temizkan R, Unal N, Engin M, Kiliçaslan Ö, Kocabay K. Herpes zoster infection in early adolescence: two case reports and review of the treatment approach. Family Pract Palliat Care. 2020;5(2):58–61. https://doi.org/10.22391/fppc.514033 . [DOI: 10.22391/fppc.514033]
  88. Terzi R, Yılmaz Z. A brachial plexus lesion secondary to herpes zoster: a case report. Turk J Phys Med Rehab. 2013;59:69–72. https://doi.org/10.4274/tftr.57625 . [DOI: 10.4274/tftr.57625]
  89. Top Karti D, Aktert D, Celebisoy N. Isolated internal ophthalmoplegia secondary to herpes zoster ophthalmicus: a rare case report. Neuroophthalmol. 2019;44(2):118–20. https://doi.org/10.1080/01658107.2019.1618343 . [DOI: 10.1080/01658107.2019.1618343]
  90. Unal B, Ahıska YC, Uslu N, Avcı S. Herpes zoster affecting the lower extremity in an older patient: a clinical image. Lupine Online J Med Sci. 2018;2(3):190–1. https://doi.org/10.32474/LOJMS.2018.02.000144 . [DOI: 10.32474/LOJMS.2018.02.000144]
  91. Yalcinbayir O, Yildiz M, Gunduz GU, Gelisken O. Herpes zoster ophthalmicus and lateral rectus palsy in an elderly patient. Case Rep Ophthalmol. 2011;2(3):333–7. https://doi.org/10.1159/000334236 . [DOI: 10.1159/000334236]
  92. Yalçınbayır Ö, Gelişken Ö, Yılmaz E. Unilateral optic neuritis in a case of herpes zoster ophthalmicus. Neuroophthalmology. 2009;33(6):339–42. [DOI: 10.3109/01658100903267608]
  93. Yorulmaz A, Hazar Tantoğlu B, Artüz F. Necrotic herpes zoster in an otherwise healthy patient. J Turkish Acad Dermatol. 2015. https://doi.org/10.6003/jtad.1593c4 . [DOI: 10.6003/jtad.1593c4]
  94. Yýlmaz S, Köseolu HK, Yücel E. Transverse myelitis caused by varicella zoster: case reports. Braz J Infect Dis. 2007;11(1):179–81. https://doi.org/10.1590/s1413-86702007000100040 . [DOI: 10.1590/s1413-86702007000100040]
  95. Yaldiz M, Solak B, Kara RO, Cosansu N, Erdem MT. Comparison of famciclovir, valaciclovir, and brivudine treatments in adult immunocompetent patients with herpes zoster. Am J Ther. 2018;25(6):e626–34. https://doi.org/10.1097/mjt.0000000000000436 . [DOI: 10.1097/mjt.0000000000000436]
  96. Asik Z, Cakmak T, Bilgili P. Knowledge, attitudes and behaviors of adults about adult vaccinations. Turk Aile Hek Dergi. 2013;17(3):113–8. https://doi.org/10.2399/tahd.13.55265 . [DOI: 10.2399/tahd.13.55265]
  97. Bayraktar-Ekincioglu A, Kara E, Bahap M, Cankurtaran M, Demirkan K, Unal S. Does information by pharmacists convince the public to get vaccinated for pneumococcal disease and herpes zoster? Irish J Med Sci. 2022;191:2193–200. https://doi.org/10.1007/s11845-021-02778-x . [DOI: 10.1007/s11845-021-02778-x]
  98. Erdogdu HI, Catak B. Influenza, pneumococcal and herpes zoster vaccination rates amongst people aged 65 years and older and related factors. Turk Geriatri Dergisi. 2018;21(4):498–506. https://doi.org/10.31086/tjgeri.2018.54 . [DOI: 10.31086/tjgeri.2018.54]
  99. İlhan B, Bakkaloglu O. Vaccination rates in geriatric outpatient clinic in Gaziantep Dr. Ersin Arslan training and research hospital. Med Bull Haseki. 2019;57:75–8. https://doi.org/10.4274/haseki.galenos.2019.4794 . [DOI: 10.4274/haseki.galenos.2019.4794]
  100. Kizmaz M, Kumtepe Kurt B, Çetin Kargin N, Döner E. Influenza, pneumococcal and herpes zoster vaccination rates among patients over 65 years of age, related factors, and their knowledge and attitudes. Aging Clin Exp Res. 2020;32(11):2383–91. https://doi.org/10.1007/s40520-019-01423-z . [DOI: 10.1007/s40520-019-01423-z]
  101. Nazik S, Nazik H, Gül F, Demir B. Herpes Zoster Hastalarının Hastalıkları ile İlgili Tutum ve Beklentileri. Firat Med J. 2016;21:137–40.
  102. Paek E, Johnson R. Public awareness and knowledge of herpes zoster: results of a global survey. Gerontology. 2010;56(1):20–31. https://doi.org/10.1159/000240046 . [DOI: 10.1159/000240046]
  103. Revanli RA, Yüceer C, Şenol E, et al. Awareness and attitude of family physicians about human papilloma virus and herpes zoster vaccines. Klimik Dergisi. 2015;29(1):15–20. https://doi.org/10.5152/kd.2016.04 . [DOI: 10.5152/kd.2016.04]
  104. Sütlü S, Til A. Immunization status and factors affecting individuals aged 65 years and above with chronic diseases who are registered with family physicians in Burdur Province. Turk Geriatri Dergisi. 2021;24(1):71–8. https://doi.org/10.31086/tjgeri.2021.201 . [DOI: 10.31086/tjgeri.2021.201]
  105. Bollaerts K, Riera-Montes M, Heininger U, et al. A systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data. Epidemiol Infect. 2017;145(13):2666–77. https://doi.org/10.1017/s0950268817001546 . [DOI: 10.1017/s0950268817001546]
  106. Turkish Statistical Institute. Elderly statistics, 2021. https://data.tuik.gov.tr/Bulten/Index?p=Elderly-Statistics-2021-45636&dil=2 . Accessed Sep 01, 2022.
  107. Chen SY, Suaya JA, Li Q, et al. Incidence of herpes zoster in patients with altered immune function. Infection. 2014;42(2):325–34. https://doi.org/10.1007/s15010-013-0550-8 . [DOI: 10.1007/s15010-013-0550-8]
  108. Huang CT, Lee CY, Sung HY, Liu SJ, Liang PC, Tsai MC. Association between diabetes mellitus and the risk of herpes zoster: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2022;107(2):586–97. https://doi.org/10.1210/clinem/dgab675 . [DOI: 10.1210/clinem/dgab675]
  109. Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine. 2002;20(19):2500–7. https://doi.org/10.1016/S0264-410X(02)00180-9 . [DOI: 10.1016/S0264-410X(02)00180-9]
  110. Joint Committee on Vaccination and Immunisation Varicella Sub-Committee. Minute of the meeting on 19 June 2015. https://app.box.com/s/vdlafy8wm4t5asq2qyfpc4dw6fzeyypf/file/149454406336 . Accessed Jun 17, 2022.
  111. Weinmann S, Chun C, Schmid DS, et al. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005–2009. J Infect Dis. 2013;208(11):1859–68. https://doi.org/10.1093/infdis/jit405 . [DOI: 10.1093/infdis/jit405]
  112. Moodley A, Swanson J, Grose C, Bonthius DJ. Severe herpes zoster following varicella vaccination in immunocompetent young children. J Child Neurol. 2019;34(4):184–8. https://doi.org/10.1177/0883073818821498 . [DOI: 10.1177/0883073818821498]
  113. Varivax Summary of Product Characteristics. https://www.medicines.org.uk/emc/files/pil.5582.pdf . Accessed Jul 10, 2023.
  114. Varilrix Summary of Product Characteristcs. https://www.medicines.org.uk/emc/product/1676/smpc/print . Accessed Jul 10, 2023.
Journal Article Review
Article has an altmetric score of 2

Word Cloud

Created with Highcharts 10.0.0HZstudiesTurkeydatareportedzosterHerpesVZVclinicalmanagementcaseepidemiologicaldiseaseviruscomplicationsPHNamongreviewsliteraturereviewlocalidentifyLiteratureprimaryreportspatientscomplicationHoweverawarenessINTRODUCTION:shinglescausedreactivationvaricellatypicallypresentsacutepainfuldermatomalrashcanleadlong-termdistressingpostherpeticneuralgiaIncreasingtrendscasesevidentgloballyagingpopulationhoweverinvestigatingepidemiologylackingThereforeconductedavailablegapsMETHODS:searchescarriedPubMedjournalsretrievepublishedarticlessurveillanceseroepidemiologypatientoutcomesrelatedApril 302022Studiesincludedsecondaryhealthyat-riskpopulationsfocusRESULTS:nationallevelOnelargeretrospectivestudyIstanbulincidenceratessignificantlyincreasedadults18-44 yearsage20112019Foursingle-centerproportiondermatological043-156%commonoccurring8-589%39identifiedophthalmicusfrequentlyTwohighlightedpoorriskperceptionTurkishcitizensCONCLUSION:OveralllimitedcomprehensiveabundanceindicatesstrongpresencediverseresearchwillimportantunderstandimpactincreasesupportintroductionnewpreventativestrategiesZosterBurdenDiseaseClinicalManagementTurkey:ComprehensiveReviewChickenpoxShinglesVaricella

Similar Articles

Cited By